164 related articles for article (PubMed ID: 37947888)
1. Low utilization of vancomycin in febrile neutropenia: real-world evidence from 4 Brazilian centers.
Ramos JF; Pereira AD; Seiwald MCN; Gandolpho LS; Molla VC; Guaraná M; Nouér SA; Nucci M; Rodrigues CA
Support Care Cancer; 2023 Nov; 31(12):687. PubMed ID: 37947888
[TBL] [Abstract][Full Text] [Related]
2. Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Vicente M; Al-Nahedh M; Parsad S; Knoebel RW; Pisano J; Pettit NN
J Oncol Pharm Pract; 2017 Dec; 23(8):575-581. PubMed ID: 27609336
[TBL] [Abstract][Full Text] [Related]
3. Early discontinuation of empirical antibiotic treatment in neutropenic patients with acute myeloid leukaemia and high-risk myelodysplastic syndrome.
Niessen FA; van Mourik MSM; Bruns AHW; Raijmakers RAP; de Groot MCH; van der Bruggen T
Antimicrob Resist Infect Control; 2020 May; 9(1):74. PubMed ID: 32460887
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant Enterococcus-Colonized Patients.
Snyder M; Pasikhova Y; Baluch A
Cancer Control; 2021; 28():10732748211045593. PubMed ID: 34558349
[TBL] [Abstract][Full Text] [Related]
5. The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN).
Perreault S; McManus D; Bar N; Foss F; Gowda L; Isufi I; Seropian S; Malinis M; Topal JE
Transpl Infect Dis; 2019 Apr; 21(2):e13059. PubMed ID: 30737868
[TBL] [Abstract][Full Text] [Related]
6. Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
Jansma B; Vakkalanka P; Talan DA; Negaard B; Faine BA
J Oncol Pharm Pract; 2020 Sep; 26(6):1382-1389. PubMed ID: 31955667
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia.
Hochart C; Berthon C; Corm S; Gay J; Cliquennois M; Tricot S; Alfandari S
Med Mal Infect; 2011 Dec; 41(12):652-6. PubMed ID: 22056376
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
Sipahi OR; Kahraman H; Erdem HA; Yetkin F; Kaya S; Demirdal T; Tunccan OG; Karasahin O; Oruc E; Cag Y; Kurtaran B; Ulug M; Kutlu M; Avci M; Oztoprak N; Arda B; Pullukcu H; Tasbakan M; Yamazhan T; Kandemir O; Dizbay M; Sipahi H; Ulusoy S
Infection; 2019 Apr; 47(2):259-266. PubMed ID: 30498901
[TBL] [Abstract][Full Text] [Related]
9. Shock and Early Death in Hematologic Patients with Febrile Neutropenia.
Guarana M; Nucci M; Nouér SA
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31405857
[TBL] [Abstract][Full Text] [Related]
10. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary Tool Kit for Febrile Neutropenia: Stewardship Guidelines,
Bartash R; Cowman K; Szymczak W; Guo Y; Ostrowsky B; Binder A; Sheridan C; Levi M; Gialanella P; Nori P
JCO Oncol Pract; 2020 Jul; 16(7):e563-e572. PubMed ID: 32048919
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of early de-escalation of empiric antimicrobial therapy in acute leukemia patients with febrile neutropenia at a large academic medical center.
Ly WJ; Brown EE; Pedretti Z; Auten J; Wilson WS
J Oncol Pharm Pract; 2023 Mar; 29(2):305-310. PubMed ID: 34927495
[TBL] [Abstract][Full Text] [Related]
13. Decrease in vancomycin-resistant Enterococcus colonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia.
Ford CD; Coombs J; Stofer MG; Lopansri BK; Webb BJ; Ostronoff F; Asch J; Hoda D
Infect Control Hosp Epidemiol; 2019 Jul; 40(7):774-779. PubMed ID: 31046849
[TBL] [Abstract][Full Text] [Related]
14. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and safety of vancomycin versus teicoplanin in febrile neutropenic patients receiving hematopoietic stem cell transplantation.
Kato-Hayashi H; Niwa T; Ohata K; Harada S; Matsumoto T; Kitagawa J; Tsurumi H; Suzuki A
J Clin Pharm Ther; 2019 Dec; 44(6):888-894. PubMed ID: 31373043
[TBL] [Abstract][Full Text] [Related]
16. Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
Karandikar MV; Milliren CE; Zaboulian R; Peiris P; Sharma T; Place AE; Sandora TJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):428-436. PubMed ID: 31603472
[TBL] [Abstract][Full Text] [Related]
17. Smaller but more frequent dosing of cefepime in the treatment of febrile neutropenia.
Okubo L; Andrick B; Rampulla R; Leri F
J Oncol Pharm Pract; 2022 Jun; 28(4):898-903. PubMed ID: 35156879
[TBL] [Abstract][Full Text] [Related]
18. The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies.
Gedik H; Yildirmak T; Simsek F; Kanturk A; Aydýn D; Anca D; Yokus O; Demirel N
Afr Health Sci; 2013 Jun; 13(2):362-8. PubMed ID: 24235937
[TBL] [Abstract][Full Text] [Related]
19. Viridans Group Streptococci in Pediatric Leukemia and Stem Cell Transplant: Review of a Risk-stratified Guideline for Empiric Vancomycin in Febrile Neutropenia.
Ruhayel SD; Foley DA; Hamilton K; Ferguson P; Kotecha RS; Bowen AC; Yeoh DK
Pediatr Infect Dis J; 2021 Sep; 40(9):832-834. PubMed ID: 34285167
[TBL] [Abstract][Full Text] [Related]
20. Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients.
Grigg SE; Date P; Loh Z; Estacio O; Johnson DF; Hawkes EA; Grigg A
Support Care Cancer; 2019 Apr; 27(4):1223-1227. PubMed ID: 30259115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
